Angiotensin and cell growth: A link to cardiovascular hypertrophy?

Journal of Hypertension

Volumn 9, Issue 1, 1991, Pages 3-15

  Schelling, Pierre ^a   Fischer, Hans ^b   Ganten, Detlev ^c  

^a Cardiovascular Research ^*  (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiotensin; Arteries; Growth factors; Heart; Hypertension; Oncogenes; Renin; Vascular hypertrophy

Indexed keywords

ANGIOTENSIN;

ANIMAL TISSUE; CATTLE; GROWTH; HUMAN; HUMAN TISSUE; HYPERTENSION; NONHUMAN; RAT; REVIEW; VASCULAR SMOOTH MUSCLE;

ADRENAL CORTEX; ANGIOTENSIN II; ANIMAL; CELL DIVISION; CELL LINE; GROWTH SUBSTANCES; HUMAN; HYPERTENSION; MUSCLE, SMOOTH, VASCULAR; RENIN-ANGIOTENSIN SYSTEM; STIMULATION, CHEMICAL;

EID: 0026083978     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: None     Document Type: Editorial

References (114)

1. Ganten D: Evidence of renin release or production in splanchnic territory. Nature 1970, 226:551–552.
2. Campbell DJ: Circulating and tissue angiotensin systems. J Clin Invest 1986, 79:1–6.
3. Dzau VJ: Cardiac renin-angiotensin system: molecular and functional aspects. Am J Med 1988, 84 (suppl 3A):22–27.
4. Ganten D, Unger T, Lang RE: The brain renin-angiotensin system: basic and functional consideration. In Research Topics in Physiology; Angiotensin and Blood Pressure Regulation edited by Harding JW et al San Diego: Academic Press Inc, 1988, pp 117–133.
5. Felix D, Imboden H, Schelung P, Harding JW: Electrophysiological assessment of central angiotensin function. In Research Topics in Physiology; Angiotensin and Blood Pressure Regulation edited by Harding JW et al. San Diego: Academic Press Inc, 1988, pp 165–208.
6. Linz W, Schölkens B, Lindpaintner K, Ganten D: Cardiac renin-angiotensin system. Am J Hypertens 1989, 2:307–310.
7. Davis JO, Freeman RH: Mechanisms regulating renin release. Physiol Rev 1976, 56:1–56.
8. Peach MJ: Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 1977, 57:313–370.
9. Lilly LS, Pratt RE, Alexander RW, et al: Renin expression by vascular endothelial cells in culture. Circ Res 1985, 57:312–318.
10. Campbell DJ, Habener JF: Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest 1986, 78:31–39.
11. Suzuki F, Ludwig G, Hellmann W, et al: Renin gene expression in rat tissues: A new quantitative assay method for rat renin mRNA using synthetic cRNA. Clin Exp Hypertens [A] 1988, 10:345–359.
12. Paul M, Wagner D, Metzger R, et al: Quantification of renin mRNA in various mouse tissues by a novel solution hybridization assay. J Hypertens 1988, 6:247–252.
13. Imboden H, Harding JW, Abhoud RH, Ganten D, Felix D: Improved immune histochemical staining of angiotensin II in rat brain using affinity purified antibodies. Brain Res 1987, 426:225–234.
14. Gunther S, Alexander RW, Atkinson WJ, Gimbrone MA: Functional angiotensin II receptors in cultured vascular smooth muscle cells. J Cell Biol 1982, 92:289–298.
15. Fuxe K, Bunnemann B, Aronsson M, et al: Pre- and postsymaptic features of the central angiotensin systems. Indications for a role of angiotensin peptides in volume transmission and for interactions with central monoamine neurons. Clin Exp Hypertens [A] 1988, 10 (suppl I):143–168.
16. Rogers TB, Gaa ST, Allen IS: Identification and characterization of functional angiotensin n receptors on cultured heart myocytes. J Pharmacol Exp Ther 1986, 236:438–444.
17. Paglin S, Stukenbrok H, Joyce NC, Jamieson JD: Interaction of angiotensin II with functional smooth muscle cells in culture. Am J Physiol 1987, 253:C872–C882.
18. Hermann K, Raizada MK, Sumners C, Phillips MI: Immunocytochemical and biochemical characterization of angiotensin I and n in cultured neuronal and glial cells from rat brain. Neuroendocrinology 1988, 47:125–132.
19. Rozengurt E: Early signals in the mitogenic response. Science 1986, 234:161–166.
20. Lopez-Rivas A, Rozengurt E: Vasopressin rapidly stimulates Ca2+ efflux from intracellular pool in quiescent Swiss 3T3 cells. Am J Physiol 1984, 247:C156–C162.
21. Rozengurt E, Sinnett-Smith JW: Bombesin induction of c-fos and c-myc proto-oncogenes in Swiss 3T3 cells: significance for the mitogenic response. J Cell Physiol 1987, 131:218–225.
22. Ganten D, Scheuing P, Flögel RM, Fischer H: Effect of angiotensin and the angiotensin antagonist PI 13 on iso-renin and cell growth in 3T3 mouse cells. IRCS Med Sci Biochem 1975, 3:327.
23. Schelung P, Ganten D, Speck G, Fischer H: Effects of angiotensin II and angiotensin II antagonist saralasin on cell growth and renin in 3T3 and SV3T3 cells. J Cell Physiol 1979, 98:503–513.
24. Emmett N, Archibold E, Harris-Hooker S, Dukes L: Effect of saralasin (angiotensin II antagonist) on 3T3 cell growth and proliferation [abstract]. J Cell Biol 1986, 103:171.
25. Emmett N, Harris-Hooker S, Archibold E: Effect of saralasin on 3T3 cell proliferation: cellular actions [abstract]. FASEB J 1988, 2:728.
26. Ganten D, Hutchinson JS, Schelung P, Ganten U, Fischer H: The iso-renin angiotensin systems in extrarenal tissue. Clin Exp Pharmacol Physiol 1976, 3:103–126.
27. Gill GN, III CR, Simonian MH: Angiotensin stimulation of bovine adrenocortical cell growth. Proc Natl Acad Sci USA 1977, 74:5569–5573.
28. Campbell-Böswell M, Robertson AL: Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Pathol 1981, 35:265–276.
29. Fischer H, FlOgel RM, Schelung P, Ganten D: Differences in endogenous iso-renin in normal and SV40 transformed 3T3 mouse cells: correlation with cell growth. IRCS Med Sci Biochem 1975, 3:328.
30. Fischer H, Schelung P, Ganten D: Suppression of endogenous iso-renin by the oncogenic virus SV40 after infection of 3T3 cells. IRCS Med Sci Biochem 1978, 6:11.
31. Ganten D, Schelung P, Vecsei P, Ganten U: Iso-renin of extrarenal origin. Am J Med 1976, 60:760–772.
32. Rebuffat P, Belloni AS, Mazzocchi G, Vassanelu P, Nussdorfer GG: A stereological study of the trophic effects of the renin-angiotensin system on the rat adrenal zona glomerulosa. J Anat 1979, 129:561–570.
33. Shelton JH, Jones AL: The fine structure of the mouse adrenal cortex and the ultrastructural changes in the zona glomerulosa with low and high sodium diets. Anat Rec 1971, 170:147–182.
34. Berk BC, Vekshtein V, Gordon HM, Tsuda T: Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989, 13:305–314.
35. Geisterfer AAT, Peach MJ, Owens GK: Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988, 62:749–756.
36. Paquet JL, Bandonim-Legros M, Brunelle G, Meyer P: Angiotensin D-induced proliferation of aortic myocytes in spontaneously hypertensive rats./Hypertens 1990, 8:565–572.
37. Lyall F, Morton JJ, Lever F, Cragoe EJ: Angiotensin II activates Na+-H+ exchange and stimulates growth in cultured vascular smooth muscle cells. J Hypertens 1988, 6 (suppl 4):S438–S441.
38. Dzau VE, Pratt R, Gbbons G, Schunkert H, Lorell B, Ingelfinger J: Molecular mechanism of angiotensin in the regulation of vascular and cardiac growth. J Mol Cell Cardiol 1989, 21 (suppl III):S7.
39. Owens GK: Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension 1987, 9:178–187.
40. Freslon IL, Guidicelu JF: Compared myocardial and vascular effects of captopril and hydralazine during hypertension development in spontaneously hypertensive rats. Br J Pharmacol 1983, 80:533–543.
41. Wang DH, Prewitt RL: Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension 1990, 15:68–77.
42. Closel JP, Kuhn H, Hefti F: Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension. J Hypertens 1989, 7:267–275.
43. Robertson AL, Khairallah PA, Angiotensin D: rapid localization in nuclei of smooth and cardiac muscle. Science 1971, 172:1138–1139.
44. Khairallah PA, Robertson AL, Davila D: Effects of angiotensin n on DNA, RNA and protein synthesis. In Hypertension’72 edited by Genest J, Koiw E. Berlin: Springer-Verlag, 1972, pp 212–220.
45. Sen S, Tarazi RC, Bumpus FM: Effect of converting enzyme inhibitor (SQ 14225) on myocardial hypertrophy in spontaneously hypertensive rats. Hypertension 1980, 2:169–176.
46. Linz W, SchOlkens BA, Ganten D: Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens [A] 1989, 11:1325–1350.
47. Todaro GJ, Habel K, Green H: Antigenic and cultural properties of cells doubly transformed by polyoma virus and SV40. Virology 1965, 27:179–185.
48. Re R, Parab M: Effect of angiotensin II on RNA synthesis by isolated nuclei. Life Sci 1984, 34:647–651.
49. Saye JA, Cassis LA, Sturgill TW, Lynch KR, Peach MJ. Angiotensinogen gene expression in 3T3–L1 cells. Am J Physiol 1989, 256:C448–C451.
50. Reid IA: Effect of angiotensin II and glucocorticoids on plasma angiotensinogen concentration in the dog. Am J Physiol 1977, 232:E234–E236.
51. Gospodarowicz D, Moran JS: Stimulation of division of sparse and confluent 3T3 cell populations by fibroblast growth factor, dexamethasone, and insulin. Proc Natl Acad Sci USA 1974, 71:4584–4588.
52. Thrash CR, Ho T, Cunningham D: Structural features of steroids which initiate proliferation of density-inhibited 3T3 mouse fibroblasts. J Biol Chem 1974, 249:6099–6103.
53. Ballard PL, Baxter JD, Higgins SJ, Rousseau GC, Tomkins GM: General presence of glucocorticoid receptors in mammalian tissues. Endocrinology 1974, 94:998–1002.
54. Klett C, Hellmann W, Müller F, et al: Angiotensin II controls angiotensinogen secretion at a pretranslational level. J Hypertens 1988, 6 (suppl 4):S442–S445.
55. Boynton AL, Whitfield JF, Isaacs RJ, Morton HJ: Control of 3T3 cell proliferation by calcium. In vitro 1974, 10:12–17.
56. Capponi AM, Lew PD, Jornot L, Vallotton MB: Correlation between cytosolic free Ca2+ and aldosterone production in bovine adrenal glomerulosa cells. J Biol Chem 1984, 259:8863–8869.
57. Smith JB, Smith L, Brown ER, etal: Angiotensin II rapidly increases phosphatidate-phosphoinositide synthesis and phosphoinositide hydrolysis and mobilizes intracellular calcium in cultured arterial muscle cells. Proc Natl Acad Sci USA 1984, 81:7812–7816.
58. Alexander RW, Brock TA, Gimbrone MA, Rtitenhouse SE: Angiotensin increases inositol triphosphate and calcium in vascular smooth muscle. Hypertension 1985, 7:447–451.
59. Nabika T, Velletri PA, Lovenberg W, Beaven MA: Increase in cytosolic calcium and phosphoinositide metabolism induced by angiotensin II and [arg] vasopressin in vascular smooth muscle cells. J Biol Chem 1985, 260:4661–4670.
60. Stumpo DJ, Blackshear PJ: Insulin and growth factor effects on c-fos expression in normal and protein kinase C-deficient 3T3–L1 fibroblasts and adipocytes. Proc Natl Acad Sci USA 1986, 83:9453–9457.
61. McCaffrey P, Ran W, Campisi J, Rosner MR: Two independent growth factor-generated signals regulate c-fos and c-myc mRNA levels in Swiss 3T3 cells. J Biol Chem 1987, 262:1442–1445.
62. Kawahara Y, Sunako M, Tsuda T, Fukuzah H, Fukumoto Y, Takai Y: Angiotensin II induced expression of the c-fos gene through protein kinase C activation and calcium ion mobilization in cultured vascular smooth muscle cells. Biochem Bicphys Res Commun 1988, 150:52–59.
63. Taubman MB, Berk BC, Izumo S, Tsuda T, Alexander RW, Nadal-Ginard B: Angiotensin n induces c-fos mRNA in aortic smooth muscle. J Biol Chem 1989, 264:526–530.
64. Nafttlan AJ, Pratt RE, Eldridge CS, Lin HL, Dzau VJ: Angiotensin n induces c-fos expression in smooth muscle via transcriptional control. Hypertension 1989, 13:706–711.
65. Young D, Watches G, Birchmeier C, Fasano O, Wiguer M: Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell 1986, 45:711–719.
66. Young D, O’Neill K, Jessell T, Wigler M: Characterization of the mas oncogene and its high-level expression in the hippocampus and cerebral cortex of rat brain. Proc Natl Acad Set USA 1988, 85:5339–5342.
67. Jackson TR, Blair AC, Marshall J, Goedert M, Hanley MR. The mas oncogene encodes an angiotensin receptor. Nature 1988, 335:437–440.
68. Spielman WS, Davis JO: The renin-angiotensin system and aldosterone secretion during sodium depletion in the rat. Circ Res 1974, 35:615–623.
69. Aguilera G, Catt KJ: Regulation of aldosterone secretion by the renin-angiotensin system during sodium restriction in rats. Proc Natl Acad Sci USA 1978, 75:4057–4061.
70. Campbell WB, Schmitz JM, Itskovitz HD: The adrenal and vascular effects of angiotensin II and III in sodium depleted rats. Life Sci 1977, 20:803–810.
71. Freeman RH, Davis JO, Lohmeier TE, Spielman WS: [Desasp1]angiotensin II: mediator of the renin-angiotensin system? Fed Proc 1977, 36:1766–1770.
72. Sybertz EJ, Ahn HS, Baum T, et al: Mechanism of the pressor response to tetradecapeptide renin substrate in the rat. Clin Exp Hypertens [A] 1984, 6:2143–2159.
73. Ryan JW: Renin-like enzyme in the adrenal gland. Science 1967, 158:1589–1590.
74. Hayduk K, Boucher R, Genest J: Renin activity content in various tissues of dogs under different physiopathological states. Proc Soc Exp Biol Med 1970, 134:252–255.
75. Ganten D, Ganten U, Kubo S, et al: Influence of sodium, potassium, and pituitary hormones on iso-renin in rat adrenal glands. Am J Physiol 1974, 227:224–229.
76. Williams GH, McDonnell LM, Raux MC, Hollenberg NK: Evidence for different angiotensin II receptors in rat adrenal glomerulosa and rabbit vascular smooth muscle cells. Circ Res 1974, 34:384–390.
77. Conn JW, Cohen EL, Lucas CP, et al: Primary reninism. Hypertension, hyperreninemia, and secondary aldosteronism due to renin-producing juxtaglomerular cell tumor. Arch Intern Med 1972, 130:682–696.
78. Aguilera G, Schirar A, Baukal A, Catt KJ: Circulating angiotensin II and adrenal receptors after nephrectomy. Nature 1981, 289:507–509.
79. Doi Y, Atarashi K, Franco-Saenz R, Mulrow PJ: Effect of changes in sodium or potassium balance, and nephrectomy, on adrenal renin and aldosterone concentrations. Hypertension 1984, 6 (suppl I):I-124–I-129
80. Mizuno K, Hoffman LH, McKenzie J, Inagami T: Presence of renin secretory granules in rat adrenal gland and stimulation of renin secretion by angiotensin II but not by adrenocorticotropin. J Clin Invest 1988, 82:1007–1016.
81. Naruse M, Inagami T: Markedly elevated specific renin levels in the adrenal in genetically hypertensive rats. Proc Natl Acad Sci USA 1982, 79:3295–3299.
82. Pratt RE, Bradshaw B, Moore TJ, Dzau VJ: Altered expression of the adrenal renin-angiotensin system in spontaneously hypertensive rats [abstract]. Circulation 1988, 78 (suppl II):II-59.
83. Mullins JJ, Peters J, Ganten D: Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990, 344:541–544.
84. Müller J: Regulation of aldosterone biosynthesis. Monogr Endocrinol 1971, 5:4–29.
85. McKenna TJ, Island DP, Nicholson WE, Uddle GW. Angiotensin stimulates both early and late steps in aldosterone biosynthesis in isolated bovine glomerulosa cells. J Steroid Biochem 1978, 9:967–972.
86. Spät A, Balla T, Endyedi P: The effect of endogenous angiotensin on the biosynthesis of aldosterone in the rat. J Steroid Biochem 1981, 14:1147–1152.
87. Campbell WB, Brady MT, Gomez-Sanchez CE: Effects of angiotensin, prostaglandin E2 and indomethacin on the early and late steps of aldosterone biosynthesis in isolated adrenal cells. J Steroid Biochem 1986, 24:865–870.
88. Kojima I, Kojima K, Rasmussen H: Effects of angiotensin II and K+ on Ca efflux and aldosterone production in adrenal glomerulosa cells. Am J Physiol 1985, 248:E36–E43.
89. Owens GK: Differential effects of antihypertensive drug therapy on vascular smooth muscle cell hypertrophy, hyperploidy and hyperplasia in the spontaneously hypertensive rat. Circ Res 1985, 56:525–536.
90. Lever AF: Slow pressor mechanisms in hypertension, a role for hypertrophy of resistance vessels? [Editorial]. J Hypertens 1986, 4:515–524.
91. Folkow B: The structural factor in primary hypertension: its relevance for future principles of treatment. J Hypertens 1987, 5 (suppl 5):S611–S613.
92. Dahlöf B: Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. Drugs 1988, 35 (suppl 5):6–26.
93. Ross R: The pathogenesis of atherosclerosis — an update. N Engl J Med 1986, 314:488–500.
94. Bauters C, Moalic JM, Bercovici J, et al: Coronary flow as a determinant of c-myc and c-fos proto-oncogene expression in an isolated adult rat heart. J Mol Cell Cardiol 1988, 20:97–101.
95. Naftilan AJ, Pratt RE, Dzau VJ: Induction of platelet-derived growth factor A-chain and c-myc gene expression by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 1989, 83:1419–1424.
96. Moauc JM, Bauters C, Himbert D, et al: Phenylephrine, vasopressin and angiotensin II as determinants of proto-oncogene and heat-shock protein gene expression in adult rat heart and aorta. J Hypertens 1989, 7:195–201.
97. Hanly MR: Proto-oncogenes in the nervous system. Neuron 1988, 1:175–182.
98. Baukal AJ, Balla T, Hunyady L, Hausdorff W, Guillemette G, Catt KJ: Angiotensin II and guanine nucleotides stimulate formation of inositol 1,4,5-triphosphate and its metabolites in permeabilized adrenal glomerulosa cells. J Biol Chem 1988, 263:6087–6092.
99. Berridge MJ, Irvine RF: Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 1984, 312:315–321.
100. Kojima I, Kojima K, Kreutter D, Rasmussen H: The temporal integration of the aldosterone secretory response to angiotensin occurs via two intracellular pathways. J Biol Chem 1984, 259:14448–14457.
101. Wilitamson JR, Cooper RH, Joseph SK, Thomas AP: Inositol triphosphate and diacylglycerol as intracellular second messengers in liver. Am J Physiol 1985, 248:C203–C216.
102. Garrison JC, Johnson DE, Campanile CP: Evidence for the role of phosphorylase kinase, protein kinase C, and other Ca2 + -sensitive protein kinases in the response of hepatocytes to angiotensin n and vasopressin. J Biol Chem 1984, 259:3283–3292.
103. Grlendung KK, Rittenhouse SE, Brock TA, Ekstein LS, Gimbrone MA, Alexander RW: Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J Biol Chem 1986, 261:5901–5906.
104. Brock TA, Lewis LJ, Smith JB: Angiotensin increases Na+ entry and Na+/H+ pump activity in cultures of smooth muscle from rat aorta. Proc Natl Acad Sci USA 1982, 79:1438–1442.
105. Berk BC, Aronow MS, Brock TA, Cragoe E, Gimbrone MA, Alexander RW: Angiotensin H-stimulated Na+/H+ exchange in cultured vascular smooth muscle cells. J Biol Chem 1987, 262:5057–5064.
106. Hatori N, Fine BP, Nakamura A, Cragoe E, Avtv A: Angiotensin n effect on cytosolic pH in cultured rat vascular smooth muscle cells. J Biol Chem 1987, 262:5073–5078.
107. Xiang JZ, SchOlkens BA, Ganten D, Unger T: Effects of sympathetic nerve stimulation are attenuated by the converting enzyme inhibitor hoe 498 in isolated rabbit hearts. Clin Exp Hypertens [A] 1984, 6:1853–1857.
108. Wright GB, Alexander RW, Ekstein LS, Gimbrone MA: Characterization of the rabbit ventricular myocardial receptor for angiotensin II. Mol Pharmacol 1983, 24:213–221.
109. Baker KM, Campanile CP, Trachte GJ, Peach MJ: Identification and characterization of the rabbit angiotensin II myocardial receptor. Circ Res 1984, 54:286–293.
110. Rogers TB: High affinity angiotensin II receptors in myocardial sarcolemmal membranes. J Biol Chem 1984, 259:8106–8114.
111. Urata H, Healy B, Stewart RW, Bumpus FM, Husain A: Angiotensin II receptors in normal and failing human hearts. J Clin Endocrinol Metah 1989, 69:54–66.
112. Freer R, Pappano A, Peach M, etal: Mechanism for the positive inotropic effect of angiotensin II on isolated cardiac muscle. Circ Res 1976, 39:178–183.
113. Kass RS, Blair ML: Effects of angiotensin II on membrane current in cardiac Purkinje fibers. J Mol Cell Cardiol 1981, 13:797–809.
114. Simpson PC: Proto-oncogenes and cardiac hypertrophy. Annu Rev Physiol 1988, 51:189–202.